These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12941385)

  • 1. A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses.
    Scheiblhofer S; Weiss R; Dürnberger H; Mostböck S; Breitenbach M; Livey I; Thalhamer J
    Microbes Infect; 2003 Sep; 5(11):939-46. PubMed ID: 12941385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines.
    Weiss R; Scheiblhofer S; Freund J; Ferreira F; Livey I; Thalhamer J
    Vaccine; 2002 Aug; 20(25-26):3148-54. PubMed ID: 12163266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.
    Gilmore RD; Kappel KJ; Dolan MC; Burkot TR; Johnson BJ
    Infect Immun; 1996 Jun; 64(6):2234-9. PubMed ID: 8675332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
    Edmondson DG; Prabhakaran S; Norris SJ; Ullmann AJ; Piesman J; Dolan M; Probst C; Radzimski C; Stöcker W; Komorowski L
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27733423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis.
    Klouwens MJ; Trentelman JJ; Ersoz JI; Nieves Marques Porto F; Sima R; Hajdusek O; Thakur M; Pal U; Hovius JW
    Sci Rep; 2021 Feb; 11(1):4775. PubMed ID: 33637813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
    Earnhart CG; Marconi RT
    Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection.
    Wagemakers A; Mason LM; Oei A; de Wever B; van der Poll T; Bins AD; Hovius JW
    Gene Ther; 2014 Dec; 21(12):1051-7. PubMed ID: 25273355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi.
    Gilmore RD; Bacon RM; Carpio AM; Piesman J; Dolan MC; Mbow ML
    J Med Microbiol; 2003 Jul; 52(Pt 7):551-556. PubMed ID: 12808075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to a Lyme disease vaccine.
    Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
    Jacquet M; Durand J; Rais O; Voordouw MJ
    Infect Genet Evol; 2015 Dec; 36():131-140. PubMed ID: 26384476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outer surface protein OspC is an antiphagocytic factor that protects Borrelia burgdorferi from phagocytosis by macrophages.
    Carrasco SE; Troxell B; Yang Y; Brandt SL; Li H; Sandusky GE; Condon KW; Serezani CH; Yang XF
    Infect Immun; 2015 Dec; 83(12):4848-60. PubMed ID: 26438793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial-infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme disease.
    Wallich R; Jahraus O; Stehle T; Tran TT; Brenner C; Hofmann H; Gern L; Simon MM
    Eur J Immunol; 2003 Mar; 33(3):708-19. PubMed ID: 12616491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
    Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
    Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Elucidation of a Protective B Cell Epitope on Outer Surface Protein C (OspC) of the Lyme Disease Spirochete, Borreliella burgdorferi.
    Rudolph MJ; Davis SA; Haque HME; Weis DD; Vance DJ; Piazza CL; Ejemel M; Cavacini L; Wang Y; Mbow ML; Gilmore RD; Mantis NJ
    mBio; 2023 Apr; 14(2):e0298122. PubMed ID: 36976016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease.
    Gipson CL; Davis NL; Johnston RE; de Silva AM
    Vaccine; 2003 Sep; 21(25-26):3875-84. PubMed ID: 12922122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences.
    Xu Q; McShan K; Liang FT
    Mol Microbiol; 2008 Jul; 69(1):15-29. PubMed ID: 18452586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.